VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
GLUE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
GLUEMonte Rosa Therapeutics, Inc.
$24.40$1.6B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksGLUEPrice History

GLUE logoMonte Rosa Therapeutics, Inc. (GLUE) Stock Price History

Historical prices from 2021 to 2026

$24.40+1.15  (+4.95%)close Jul 7
Returns
1M
+43.5%
3M
+42.5%
YTD
+59.4%
1Y
+390.9%
3Y
+53.9%
5Y
+4.4%
ATH$45.56Sep 2021-46.4%
ATL$2.44Oct 2023pre-split
Avg Vol (50D)982K/ day
52-Week Range$4.12 — $25.77
LowCurrent: $24.40High

Loading 10-year price history...

GLUE Historical Performance

1 YearTotal Return
+390.9%
Price: +390.9%
3 YearsTotal Return
+264.7%
CAGR: +53.9%
Price: +264.7%
5 YearsTotal Return
+24.3%
CAGR: +4.4%
Price: +24.3%
YTD
+59.4%

GLUE Annual Returns

Year-by-year price performance · 2021–2026

Best+120.5%2025
Worst-62.7%2022
Up years3/6
2021-3.6%
2022-62.7%
2023-27.4%
2024+21.5%
2025+120.5%
2026+15.9%
2021 annual price return
-3.6%
2022 annual price return
-62.7%
2023 annual price return
-27.4%
2024 annual price return
+21.5%
2025 annual price return
+120.5%
2026 annual price return
+15.9%
LessMore
Alpha vs S&P 500
1Y+319.0%
3Y+25.6%
5Y-12.0%

Price returns only.

Download Historical Data

1,264 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

GLUE Stock Price Trajectory (2021–2026)

As of July 8, 2026, Monte Rosa Therapeutics, Inc. (GLUE) trades at $24.40, representing a +390.9% return over the past year. The stock has delivered a +24.3% total return over five years (+4.4% CAGR), reflecting significant long-term value creation.

The stock reached its all-time high of $45.56 on September 7, 2021. From this peak, GLUE has corrected -46.4%, currently trading 45% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers ARVN (+10.3% 1Y), KYMR (+172.2% 1Y), and PRAX (+594.0% 1Y), GLUE has underperformed the peer group average. Compare GLUE vs ARVN →

GLUE Historical Price Data · from 2021

Rows 1–50 of 1,264
Date Open High Low Close Volume Change %
2026-07-0723.4924.9823.0424.401.28M+4.95%
2026-07-0624.0524.2422.9423.25980K-3.97%
2026-07-0223.6425.2223.2224.211.34M+0.79%
2026-07-0123.8525.0323.7824.021.30M-0.74%
2026-06-3024.2024.7523.4624.201.78M+1.26%
2026-06-2922.5923.9822.5923.901.41M+7.22%
2026-06-2621.6622.3720.9222.290+2.91%
2026-06-2520.7622.3320.4021.661.73M+3.88%
2026-06-2421.0022.1520.6320.852.26M+0.68%
2026-06-2318.4420.9718.3820.711.73M+10.93%
2026-06-2218.9119.2317.9118.671.72M+1.97%
2026-06-1819.0719.3117.9418.312.17M-0.54%
2026-06-1717.9319.2217.9318.411.17M+3.66%
2026-06-1618.0418.5017.3817.76697K-1.99%
2026-06-1518.5418.8517.8818.12735K-0.63%
2026-06-1217.3418.3217.2118.231.08M+6.64%
2026-06-1116.5417.3116.3917.101.38M+3.51%
2026-06-1016.9917.2916.2816.52841K-0.54%
2026-06-0917.6817.8316.1516.61818K-2.29%
2026-06-0816.5617.0416.1117.002.01M+3.85%
2026-06-0517.4517.8016.2516.37917K-5.70%
2026-06-0417.4818.0717.0917.36707K-1.31%
2026-06-0317.8718.0217.3017.59882K-0.85%
2026-06-0219.2719.3817.7217.74972K-9.81%
2026-06-0119.7519.8618.6319.67976K-0.20%
2026-05-2919.8720.3619.2319.711.01M+1.65%
2026-05-2819.2019.5518.8819.391.17M+1.15%
2026-05-2719.3320.1119.0819.17553K-0.16%
2026-05-2619.1019.5818.8319.20659K+2.07%
2026-05-2218.7218.8118.4518.81857K-0.37%
2026-05-2118.0119.1617.8918.88718K+1.23%
2026-05-2017.9318.9617.8118.65879K+6.09%
2026-05-1917.9518.0217.4417.58617K-2.39%
2026-05-1818.3318.5717.6718.01568K-0.77%
2026-05-1518.4618.5417.9318.15916K-2.84%
2026-05-1418.9819.1618.6018.68451K-1.48%
2026-05-1318.8419.0818.6218.96662K-0.78%
2026-05-1219.8820.0219.0019.11505K-5.68%
2026-05-1119.7721.2719.6420.26972K+4.49%
2026-05-0820.1120.1119.1619.39525K-2.12%
2026-05-0720.2520.3019.2419.81656K-2.84%
2026-05-0619.4720.7219.1220.391.08M+5.37%
2026-05-0519.8119.9718.8319.35536K-1.12%
2026-05-0418.8119.8918.7619.57732K+4.10%
2026-05-0119.0419.4418.6618.80624K-1.83%
2026-04-3019.1319.2118.7119.15451K+2.30%
2026-04-2918.7719.0418.5018.72517K-1.53%
2026-04-2819.1619.8518.6819.01571K-1.45%
2026-04-2720.2520.2519.0419.29464K-2.53%
2026-04-2420.2320.4519.4419.79525K-1.88%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

GLUE — Frequently Asked Questions

Quick answers to the most common questions about buying GLUE stock.

How has GLUE stock performed recently?

GLUE returned +390.9% over the past year, beating its 5-year annualized CAGR of +4.4%. The stock trades above its 200-day moving average, confirming the uptrend.

What is GLUE's all-time high price?

Monte Rosa Therapeutics, Inc. reached $45.56 on 2021-09-07. The 52-week high is $25.77. Current 1-year return of +390.9% places the stock closer to historical peaks.

Where can I download GLUE historical price data?

This page provides GLUE daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2021-2026, downloadable in CSV format.

422 data points · sampled from 1,264